A new ELZA review in Die Ophthalmologie examines the mechanisms, clinical evidence, protocol selection, and indications for PACK-CXL in infectious keratitis.
A new publication in JRS reports the long-term endothelial safety of the ELZA-sub400 protocol for treating progressive keratoconus in corneas thinner than 400 µm.
Dual chromophore PACK-CXL treatment using riboflavin/UV-A and rose bengal/green light may offer an effective solution for refractory Acanthamoeba keratitis.